06/23/2025 07:15
Brighter Signals Emerges from Stealth

Brighter Signals B.V. (https://www.brightersignals.com), a sensing technology startup founded by serial entrepreneurs Andrew Klein, Christine Fraser and Edward Shim, today announced its launch and the acquisition of a breakthrough portfolio of patents for high-depth multi-modal tactile sensors made wholly of fabrics. Backed by early-stage VC firm Antler, Brighter Signals has developed a sensor platform over ten years that offers unprecedented high-depth tactile sensitivity, flexibility, and e...

06/18/2025 04:30
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials

Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to prov...

07/07/2025 09:59
TH Global Capital Closes 4 Major M&A Deals in Australia in 4 Months Including the Sale of The Missing Link to Infosys

TH Global Capital, an award-winning global boutique investment bank with a presence in 13 countries, has closed four high profile deals in the first four months of 2025, including the sale of The Missing Link to Infosys for 120 million AUD. This marks its tenth cross border transaction in Australia over the past 18 months, cementing its position as the mid-market M&A boutique investment bank of choice in Australia and New Zealand. Sale of The Missing Link to Infosys – The Missing Link, a...

06/18/2025 05:00
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years

Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy of Nemluvio in moderate-to-severe prurigo nodularis. The new data show Nemluvio is well tolerated and associated with sustained and clinically meaningful improvements in symptoms including itch and skin lesions, during prolonged treatment up to two years.1 These new data will be presented as a late-breaking session at ICD, on Saturday, June 21, 2025 at 08:30 AM CET. ...

07/01/2025 09:30
LTIMindtree Launches GCC-as-a-Service

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company today introduced its GCC-as-a-Service. The services cater to organizations that may want to set up GCCs, scale their existing ones to optimize costs and create added value. The catalogue covers a spectrum of Build, Operate, Transform and Transfer services, offering clients the option to pick and choose what they require. GCC-as-a-Service commercials are designed on a per-seat or per service basi...

06/18/2025 06:00
Ververica Announces Partnership with Aiven - Empowering Leading Enterprises to Create Value from their Data in Real-Time

Ververica, the original creators of Apache Flink® and a leader in stream processing technology, today announced a new partnership with Aiven, the AI-ready open source cloud data platform. This partnership enables Aiven to provide Ververica’s Unified Streaming Data Platform to their customers, expanding access to enterprise-grade streaming data capabilities for data-driven businesses around the world. This press release features multimedia. View the full release here: https://www.businesswire.c...

06/18/2025 06:00
Yokogawa Collaborates with Shell on Robotics and AI Technology for Plant Maintenance

Yokogawa Electric Corporation (TOKYO: 6841) announces that it has formalized a long-term agreement with Shell Global Solutions International B.V. (“Shell”) to integrate and further develop technologies for utilizing robots and drones in plant monitoring and maintenance. Under the agreement, Yokogawa will add an advanced machine vision tool called Operator Round by Exception (ORE), developed by Shell, into its own OpreX™ Robot Management Core. The enhanced software service will be made available...

07/07/2025 10:21
Reply AI Music Contest - Announced the Winner of the First International Competition Connecting AI Technologies With Music and Live Performances

Reply, an international group specialized in the creation of new business models enabled by Artificial Intelligence, is proud to announce the winner of the first edition of the Reply AI Music Contest —an international competition, organized in collaboration with the Kappa FuturFestival, aimed at creatives from around the world interested in exploring new ways to combine music, visuals, and AI technologies within live performances. This press release features multimedia. View the full release h...

06/18/2025 07:00
Americhem Aligns European Region Under Global Brand

Americhem Inc., a global leader in polymer solutions, has unified its European operations under the Americhem brand—streamlining customer experience and reinforcing alignment across global quality and manufacturing standards. “This move simplifies how we scale and serve,” said CEO John Richard. “One brand delivers clarity, consistency, and confidence.” The Denmark site supports Americhem’s healthcare strategy, producing ISO 13485 compounds for hearing aids, surgical tools, and drug delivery...